Posted: 14 Dec 2015 09:31 AM PST
By Alan M. Kirschenbaum –
If you’re looking for Holiday reading, CMS has a gift for you!
OMB’s Office of Information Regulatory Affairs (OIRA) has completed its review of a long-awaited CMS final regulation implementing significant changes to the Medicaid Drug Rebate Program. Completion of the review was announced on OIRA’s website here. It typically takes a lengthy regulation from several days to two weeks after OMB release before it is posted for pre-publication review.
We’ll be posting a notice in the FDA Law Blog when the rule is released, and following its release, we’ll be preparing a memo to summarize it. We’ll also be conducting a webinar on the rule in collaboration with KPMG’s government pricing group. The date and other details will be announced on this blog in the near future.
If you’re looking for Holiday reading, CMS has a gift for you!
OMB’s Office of Information Regulatory Affairs (OIRA) has completed its review of a long-awaited CMS final regulation implementing significant changes to the Medicaid Drug Rebate Program. Completion of the review was announced on OIRA’s website here. It typically takes a lengthy regulation from several days to two weeks after OMB release before it is posted for pre-publication review.
We’ll be posting a notice in the FDA Law Blog when the rule is released, and following its release, we’ll be preparing a memo to summarize it. We’ll also be conducting a webinar on the rule in collaboration with KPMG’s government pricing group. The date and other details will be announced on this blog in the near future.
.png)
No hay comentarios:
Publicar un comentario